Skip to content

Clinical trials

Recruiting Carcinoma, Non-Small-Cell Lung trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Recruiting Country / region: United States Clear all

440 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20051
20081
20122
20142
20151
20165
20174
20186
20196
202016
202122
202236
202354
202472
2025124
202683

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting440

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Memorial Sloan Kettering Cancer Center14
Bristol-Myers Squibb13
AstraZeneca12
Merck Sharp & Dohme LLC12
National Cancer Institute (NCI)10
City of Hope Medical Center8
M.D. Anderson Cancer Center8
Revolution Medicines, Inc.8
AbbVie7
BioNTech SE7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung440
Lung Neoplasms132
Colorectal Neoplasms67
Melanoma53
Squamous Cell Carcinoma of Head and Neck49
Neoplasm Metastasis48
Neoplasms45
Triple Negative Breast Neoplasms44
Breast Neoplasms39
Carcinoma, Renal Cell39

Trials

Showing 1 to 25 of 440. Each trial links to its page on Pharma Observatory.

340 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.